VIDEO: Declining rate of HPV vaccination in adolescents

Article

Dr Anne Schuchat, Assistant Surgeon General and Director of the Centers for Disease Control and Prevention's (CDC) National Center for Immunization and Respiratory Diseases, discusses the recent CDC report on declining humanpapillomavirus vaccine rates in adolescents.

Dr Anne Schuchat, Assistant Surgeon General and Director of the Centers for Disease Control and Prevention's (CDC) National Center for Immunization and Respiratory Diseases, discusses the recent CDC report on declining humanpapillomavirus vaccine rates in adolescents.

Recent Videos
Tina Tan, MD, comments on FDA expanded approval for MenQuadfi meningococcal disease vaccine
Tina Tan, MD
Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP
Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP
Mary Koslap-Petraco, DNP, PPCNP-BC, CPNP, FAANP
Tina Tan, MD
Robert Frenck, MD
Importance of maternal influenza vaccination recommendations
Samantha Olson, MPH
Related Content
CDC: Healthy children can receive COVID-19 vaccine via "shared clinical decision-making" | Image Credit: © ricka_kinamoto - © ricka_kinamoto - stock.adobe.com.

CDC: Healthy children can receive COVID-19 vaccine via 'shared clinical decision-making'

Joshua Fitch, Senior Editor
June 2nd 2025
Article

In this article, we recap a timeline of recent federal agency changes to routine COVID-19 vaccination intended for the pediatric population.

What's going on with polio, monkeypox, and COVID-19

What's going on with polio, monkeypox, and COVID-19

Miranda Hester
August 19th 2022
Podcast

The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?

Nirsevimab demonstrates sustained efficacy in reducing RSV hospitalizations through 6 months | Image Credit: © Peter Hansen - © Peter Hansen - stock.adobe.com.

Nirsevimab demonstrates sustained efficacy in reducing RSV hospitalizations through 6 months

Joshua Fitch, Senior Editor
May 29th 2025
Article

New phase 3b durability data revealed nirsevimab reduced RSV hospitalizations in infants by 82.7% through 180 days vs no intervention.

What Omicron could mean for the pandemic

What Omicron could mean for the pandemic

Miranda Hester
January 7th 2022
Podcast

Contemporary Pediatrics sat down with Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, to discuss what's known about the variant. She also discusses the latest on the vaccine for children aged younger than 5 years.

5 pediatric FDA decisions to watch for in Q2 2025Latest revision | Image Credit: © Araki Illustrations - © Araki Illustrations - stock.adobe.com.

5 pediatric FDA decisions to watch for in Q2 2025

Morgan Ebert, Managing Editor;Joshua Fitch, Senior Editor
Published: March 28th 2025 | Updated: March 28th 2025
Article

A look ahead to 5 key regulatory decisions scheduled to take place during the second quarter of 2025, from a monoclonal antibody to topical psoriasis treatments.

Tina Tan, MD

Tina Tan, MD, comments on the measles outbreak in Texas, vaccine-preventable diseases

Joshua Fitch, Senior Editor ;John Parkinson;Tina Q Tan, MD, FAAP, FIDSA, FPIDS
February 27th 2025
Article

"The measles outbreak that is currently happening in Texas and New Mexico is occurring in an area of the states that have very high anti-vaccine sentiments," Tan said.

© 2025 MJH Life Sciences

All rights reserved.